Vorwerk Ventures is an independent € 150m Venture Capital Fund with € 400m under management. We invest in founders with sustainable business models that have a positive impact. We define ourselves through a strong commitment towards consumer-facing digital businesses, but we also go beyond and invest in selected B2B companies that match our sector expertise. Our unique experience in addition to an outstanding track record provides added value for forward-thinking tech entrepreneurs. Headquartered in Berlin Germany, we are constantly on the look-out for promising opportunities starting with Seed/Series A investments of € 1m to € 10m and ensuring continuous support by reserving up to € 15m for upcoming financing rounds. An outstanding founding team, a unique product or service addressing a substantial market framed by a strong business model are key requirements to us when it comes to making an investment decision.

Archimed is an investment firm focused on the acquisition, expansion, and internationalization of healthcare sector globally.

Universit_tsklinikum Essen is a medical university and has developed an app iNephro Medikamentenplan for iPhone and iPad users.

Developer of a caregiving assistance application designed to organize the challenges of home care effectively. The company's platform offers an intelligent assistant to provide individualized answers to questions, detailed guides, the option to chat with experts, step-by-step guidance, care plans, and checklists, enabling caregivers with the tools, information, and support they need to fulfill their responsibilities.

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Provider of sexual health services headquartered in London, England. The company offers services such as access to STI testing, chlamydia treatment, partner notification, and contraception and clinicians are available to advise and support by text message, phone or email.

Lindus Health is a clinical research organization running clinical trials. Their services include ethics, IRB submission, trial monitoring, data management, biostatistics, regulatory, and payor affairs. They also provide EDC, database, site, and feasibility products.

Roche is a pharmaceutical and diagnostics company that focused on improving people’s lives. Roche is the owner of F. Hoffmann-La Roche Ltd. Roche is a provider of in-vitro diagnostics and drugs for cancer and transplantation. It specializes in medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. F. Hoffmann-La Roche Ltd. serves hospitals, research labs, private medical labs, practicing physicians, and patients. Its products include cancer treatments, such as Avastin, Herceptin, and MabThera which are also effective in the treatment of rheumatoid arthritis, anemia, and osteoporosis. F. Hoffmann-La Roche Ltd. also conducts research and development as well as production related to molecular diagnostic reagents, test systems, and test kits. In addition, it provides automated instruments, software, consumables, and IT solutions used in in-vitro diagnostics and research.

Tandem Health SC is a Sumter, SC based private company whose line of business is Medical doctor's office

Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.